PESHAWAR, Nov 03 (APP):Professor Dr. Abdul Jalil Khan, Vice-Chancellor of Khyber Medical University (KMU), Peshawar, participated in a five-day, face-to-face meeting of the World Health Organization (WHO) Guideline Development Group (GDG), held from 26 to 30 October 2026 in Geneva, Switzerland, to contribute to the development of international guidelines on the management of dyslipidemia for the primary and secondary prevention of cardiovascular disease. According to a press release issued here …
VC KMU represents Pakistan at WHO Global Guideline Development meeting in Geneva
PESHAWAR, Nov 03 (APP):Professor Dr. Abdul Jalil Khan, Vice-Chancellor of Khyber Medical University (KMU), Peshawar, participated in a five-day, face-to-face meeting of the World Health Organization (WHO) Guideline Development Group (GDG), held from 26 to 30 October 2026 in Geneva, Switzerland, to contribute to the development of international guidelines on the management of dyslipidemia for the primary and secondary prevention of cardiovascular disease.
According to a press release issued here on Tuesday, Professor Jalil Khan, who was previously selected as an expert member of this prestigious WHO committee through an international selection process, is the only expert selected from Pakistan for the Guideline Development Group.
His selection reflects international recognition of his expertise in Family Medicine, primary healthcare, public health, and health systems strengthening.
The WHO Guideline Development Group brings together distinguished international experts from leading academic, clinical, and research institutions worldwide, representing expertise in cardiology, internal medicine, endocrinology, epidemiology, public health, and evidence-based guideline development.
The Geneva meeting provided an important opportunity for experts to collectively review scientific evidence and contribute to the development of evidence-informed recommendations for the prevention and management of cardiovascular disease, particularly through improved identification and management of dyslipidemia, a major risk factor for heart attacks and strokes.
Professor Jalil Khan’s participation brought valuable perspectives from primary healthcare systems and low- and middle-income countries, particularly the importance of developing practical, equitable, and evidence-based recommendations that can be implemented across different healthcare settings.
With extensive clinical and academic experience in the United Kingdom’s National Health Service (NHS), alongside his leadership in Family Medicine, primary healthcare development, and health systems strengthening in Pakistan, Professor Jalil Khan brings a unique combination of international clinical expertise and practical health systems experience to this global initiative.
The development of these WHO guidelines is expected to support countries in strengthening cardiovascular disease prevention, improving clinical decision-making, and integrating effective management of non-communicable diseases into primary healthcare services.
Professor Jalil Khan’s participation in this important international initiative highlights the growing contribution of Pakistani healthcare professionals to global health policy and evidence-based guideline development, while further strengthening KMU’s international academic profile.
